125 related articles for article (PubMed ID: 33516583)
1. Potential Clinical and Economic Value of Norovirus Vaccination in the Community Setting.
Bartsch SM; O'Shea KJ; Wedlock PT; Ferguson MC; Siegmund SS; Lee BY
Am J Prev Med; 2021 Mar; 60(3):360-368. PubMed ID: 33516583
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of pediatric norovirus vaccination in daycare settings.
Steimle LN; Havumaki J; Eisenberg MC; Eisenberg JNS; Prosser LA; Pike J; Ortega-Sanchez IR; Mattison CP; Hall AJ; Steele MK; Lopman BA; Hutton DW
Vaccine; 2021 Apr; 39(15):2133-2145. PubMed ID: 33741192
[TBL] [Abstract][Full Text] [Related]
3. What Is the Value of Different Zika Vaccination Strategies to Prevent and Mitigate Zika Outbreaks?
Bartsch SM; Asti L; Cox SN; Durham DP; Randall S; Hotez PJ; Galvani AP; Lee BY
J Infect Dis; 2019 Aug; 220(6):920-931. PubMed ID: 30544164
[TBL] [Abstract][Full Text] [Related]
4. The impact and cost-effectiveness of controlling cholera through the use of oral cholera vaccines in urban Bangladesh: A disease modeling and economic analysis.
Khan AI; Levin A; Chao DL; DeRoeck D; Dimitrov DT; Khan JAM; Islam MS; Ali M; Islam MT; Sarker AR; Clemens JD; Qadri F
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006652. PubMed ID: 30300420
[TBL] [Abstract][Full Text] [Related]
5. The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age.
Bartsch SM; Asti L; Stokes-Cawley OJ; Sim SY; Bottazzi ME; Hotez PJ; Lee BY
Am J Prev Med; 2020 Mar; 58(3):370-377. PubMed ID: 31980305
[TBL] [Abstract][Full Text] [Related]
6. Economics of influenza vaccine administration timing for children.
Lee BY; Tai JH; Bailey RR; Smith KJ; Nowalk AJ
Am J Manag Care; 2010 Mar; 16(3):e75-e85. PubMed ID: 20205492
[TBL] [Abstract][Full Text] [Related]
7. The potential economic value of a therapeutic Chagas disease vaccine for pregnant women to prevent congenital transmission.
Bartsch SM; Stokes-Cawley OJ; Buekens P; Asti L; Bottazzi ME; Strych U; Wedlock PT; Mitgang EA; Meymandi S; Falcon-Lezama JA; Hotez PJ; Lee BY
Vaccine; 2020 Apr; 38(16):3261-3270. PubMed ID: 32171575
[TBL] [Abstract][Full Text] [Related]
8. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy].
Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E
Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779
[TBL] [Abstract][Full Text] [Related]
9. Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Scholz SM; Weidemann F; Damm O; Ultsch B; Greiner W; Wichmann O
Value Health; 2021 Jan; 24(1):32-40. PubMed ID: 33431151
[TBL] [Abstract][Full Text] [Related]
10. Targeting pediatric versus elderly populations for norovirus vaccines: a model-based analysis of mass vaccination options.
Steele MK; Remais JV; Gambhir M; Glasser JW; Handel A; Parashar UD; Lopman BA
Epidemics; 2016 Dec; 17():42-49. PubMed ID: 27821278
[TBL] [Abstract][Full Text] [Related]
11. Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea.
Kim YK; Song JY; Jang H; Kim TH; Koo H; Varghese L; Han E
Pharmacoeconomics; 2018 Dec; 36(12):1475-1490. PubMed ID: 30251078
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of an adjuvanted recombinant zoster vaccine in older adults in the United States who have been previously vaccinated with zoster vaccine live.
Curran D; Patterson BJ; Van Oorschot D; Buck PO; Carrico J; Hicks KA; Lee B; Yawn BP
Hum Vaccin Immunother; 2019; 15(4):765-771. PubMed ID: 30625011
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Hornberger J; Robertus K
Ann Intern Med; 2006 Sep; 145(5):317-25. PubMed ID: 16954357
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT; Nagy L; Dolk FCK; Wilschut JC; Pitman R; Postma MJ
Value Health; 2021 Jan; 24(1):19-31. PubMed ID: 33431149
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer prevention in Indonesia: An updated clinical impact, cost-effectiveness and budget impact analysis.
Setiawan D; Andrijono ; Hadinegoro SR; Meyta H; Sitohang RV; Tandy G; Perwitasari DA; Postma MJ
PLoS One; 2020; 15(3):e0230359. PubMed ID: 32203527
[TBL] [Abstract][Full Text] [Related]
16. Vaccinating children against influenza: overall cost-effective with potential for undesirable outcomes.
de Boer PT; Backer JA; van Hoek AJ; Wallinga J
BMC Med; 2020 Jan; 18(1):11. PubMed ID: 31931789
[TBL] [Abstract][Full Text] [Related]
17. Incremental cost-effectiveness evaluation of vaccinating girls against cervical cancer pre- and post-sexual debut in Belgium.
Demarteau N; Van Kriekinge G; Simon P
Vaccine; 2013 Aug; 31(37):3962-71. PubMed ID: 23777952
[TBL] [Abstract][Full Text] [Related]
18. Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting.
Bartsch SM; Hotez PJ; Hertenstein DL; Diemert DJ; Zapf KM; Bottazzi ME; Bethony JM; Brown ST; Lee BY
Vaccine; 2016 Apr; 34(19):2197-206. PubMed ID: 27002501
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.
Vučina VV; Filipović SK; Kožnjak N; Stamenić V; Clark AD; Mounaud B; Blau J; Hoestlandt C; Kaić B
Vaccine; 2015 May; 33 Suppl 1():A209-18. PubMed ID: 25919163
[TBL] [Abstract][Full Text] [Related]
20. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
